APO Research

APO RESEARCH · REPORT

Pharmaceuticals and Excipients

Selected research

Market Analysis & Forecast

Global Pharmaceuticals and Excipients Market Analysis and Forecast 2026-2032

Market perspective

The global Pharmaceuticals and Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharmaceuticals and Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceuticals and Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceuticals and Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceuticals and Excipients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pharmaceuticals and Excipients include Signet Chemical Corporation, Sigachi Industries, Shin-Etsu, Roquette, MEGGLE AG, Lubrizol, JRS Pharma, Evonik and ER-KANG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharmaceuticals and Excipients, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceuticals and Excipients, also provides the sales of main regions and countries. Of the upcoming market potential for Pharmaceuticals and Excipients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceuticals and Excipients sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceuticals and Excipients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceuticals and Excipients sales, projected growth trends, production technology, application and end-user industry.

Pharmaceuticals and Excipients Segment by Company

Signet Chemical Corporation

Sigachi Industries

Shin-Etsu

Roquette

MEGGLE AG

Lubrizol

JRS Pharma

Evonik

ER-KANG

Dow

BASF

Ashland

ABITEC Corp

Pharmaceuticals and Excipients Segment by Type

Starch

Mannitol

Triglycerides

Dextrose

Sorbitol

Sucrose

Others

Pharmaceuticals and Excipients Segment by Application

Parenteral Formulations

Topical Formulations

Oral Formulations

Other

Pharmaceuticals and Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals and Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals and Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals and Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pharmaceuticals and Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharmaceuticals and Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceuticals and Excipients sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceuticals and Excipients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Starch Major Manufacturers Table 3. Mannitol Major Manufacturers Table 4. Triglycerides Major Manufacturers Table 5. Dextrose Major Manufacturers Table 6. Sorbitol Major Manufacturers Table 7. Sucrose Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Pharmaceuticals and Excipients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Parenteral Formulations Major Manufacturers Table 11. Topical Formulations Major Manufacturers Table 12. Oral Formulations Major Manufacturers Table 13. Other Major Manufacturers Table 14. Pharmaceuticals and Excipients Industry Trends Table 15. Pharmaceuticals and Excipients Industry Drivers Table 16. Pharmaceuticals and Excipients Industry Opportunities and Challenges Table 17. Pharmaceuticals and Excipients Industry Restraints Table 18. Global Pharmaceuticals and Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceuticals and Excipients Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Pharmaceuticals and Excipients Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2021-2026) Table 22. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2027-2032) Table 23. Global Pharmaceuticals and Excipients Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Pharmaceuticals and Excipients Sales by Region (2021-2026) & (Tons) Table 25. Global Pharmaceuticals and Excipients Sales by Region (2027-2032) & (Tons) Table 26. Global Pharmaceuticals and Excipients Sales Market Share by Region (2021-2026) Table 27. Global Pharmaceuticals and Excipients Sales Market Share by Region (2027-2032) Table 28. Global Pharmaceuticals and Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Pharmaceuticals and Excipients Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Pharmaceuticals and Excipients Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Pharmaceuticals and Excipients Sales Market Share by Manufacturers (2021-2026) Table 32. Global Pharmaceuticals and Excipients Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Pharmaceuticals and Excipients Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pharmaceuticals and Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Pharmaceuticals and Excipients Manufacturers, Product Type & Application Table 36. Global Pharmaceuticals and Excipients Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Pharmaceuticals and Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pharmaceuticals and Excipients Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2026) Table 43. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2027-2032) Table 44. Global Pharmaceuticals and Excipients Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 45. Global Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 46. Global Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 47. Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2026) Table 48. Global Pharmaceuticals and Excipients Sales Market Share by Type (2027-2032) Table 49. Global Pharmaceuticals and Excipients Price by Type (2021-2026) & (US$/Ton) Table 50. Global Pharmaceuticals and Excipients Price by Type (2027-2032) & (US$/Ton) Table 51. Global Pharmaceuticals and Excipients Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2026) Table 55. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2027-2032) Table 56. Global Pharmaceuticals and Excipients Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 57. Global Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 58. Global Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 59. Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2026) Table 60. Global Pharmaceuticals and Excipients Sales Market Share by Application (2027-2032) Table 61. Global Pharmaceuticals and Excipients Price by Application (2021-2026) & (US$/Ton) Table 62. Global Pharmaceuticals and Excipients Price by Application (2027-2032) & (US$/Ton) Table 63. Signet Chemical Corporation Company Information Table 64. Signet Chemical Corporation Business Overview Table 65. Signet Chemical Corporation Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio Table 67. Signet Chemical Corporation Recent Development Table 68. Sigachi Industries Company Information Table 69. Sigachi Industries Business Overview Table 70. Sigachi Industries Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Sigachi Industries Pharmaceuticals and Excipients Product Portfolio Table 72. Sigachi Industries Recent Development Table 73. Shin-Etsu Company Information Table 74. Shin-Etsu Business Overview Table 75. Shin-Etsu Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Shin-Etsu Pharmaceuticals and Excipients Product Portfolio Table 77. Shin-Etsu Recent Development Table 78. Roquette Company Information Table 79. Roquette Business Overview Table 80. Roquette Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Roquette Pharmaceuticals and Excipients Product Portfolio Table 82. Roquette Recent Development Table 83. MEGGLE AG Company Information Table 84. MEGGLE AG Business Overview Table 85. MEGGLE AG Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. MEGGLE AG Pharmaceuticals and Excipients Product Portfolio Table 87. MEGGLE AG Recent Development Table 88. Lubrizol Company Information Table 89. Lubrizol Business Overview Table 90. Lubrizol Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Lubrizol Pharmaceuticals and Excipients Product Portfolio Table 92. Lubrizol Recent Development Table 93. JRS Pharma Company Information Table 94. JRS Pharma Business Overview Table 95. JRS Pharma Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. JRS Pharma Pharmaceuticals and Excipients Product Portfolio Table 97. JRS Pharma Recent Development Table 98. Evonik Company Information Table 99. Evonik Business Overview Table 100. Evonik Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Evonik Pharmaceuticals and Excipients Product Portfolio Table 102. Evonik Recent Development Table 103. ER-KANG Company Information Table 104. ER-KANG Business Overview Table 105. ER-KANG Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. ER-KANG Pharmaceuticals and Excipients Product Portfolio Table 107. ER-KANG Recent Development Table 108. Dow Company Information Table 109. Dow Business Overview Table 110. Dow Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Dow Pharmaceuticals and Excipients Product Portfolio Table 112. Dow Recent Development Table 113. BASF Company Information Table 114. BASF Business Overview Table 115. BASF Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. BASF Pharmaceuticals and Excipients Product Portfolio Table 117. BASF Recent Development Table 118. Ashland Company Information Table 119. Ashland Business Overview Table 120. Ashland Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Ashland Pharmaceuticals and Excipients Product Portfolio Table 122. Ashland Recent Development Table 123. ABITEC Corp Company Information Table 124. ABITEC Corp Business Overview Table 125. ABITEC Corp Pharmaceuticals and Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. ABITEC Corp Pharmaceuticals and Excipients Product Portfolio Table 127. ABITEC Corp Recent Development Table 128. North America Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 131. North America Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 132. North America Pharmaceuticals and Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 133. North America Pharmaceuticals and Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 134. North America Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 135. North America Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 136. North America Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 137. North America Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 138. North America Pharmaceuticals and Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 139. North America Pharmaceuticals and Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 140. North America Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. North America Pharmaceuticals and Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. North America Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 144. North America Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 145. North America Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 146. North America Pharmaceuticals and Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 147. North America Pharmaceuticals and Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 148. United States Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 149. Canada Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 150. Europe Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 153. Europe Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 154. Europe Pharmaceuticals and Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 155. Europe Pharmaceuticals and Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 156. Europe Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 159. Europe Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 160. Europe Pharmaceuticals and Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 161. Europe Pharmaceuticals and Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 162. Europe Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Europe Pharmaceuticals and Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Europe Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 166. Europe Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 167. Europe Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 168. Europe Pharmaceuticals and Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 169. Europe Pharmaceuticals and Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 170. Germany Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 171. France Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 172. U.K. Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 173. Italy Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 174. Netherlands Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 175. China Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 176. China Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 177. China Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 178. China Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 179. China Pharmaceuticals and Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 180. China Pharmaceuticals and Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 181. China Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 182. China Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 183. China Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 184. China Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 185. China Pharmaceuticals and Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 186. China Pharmaceuticals and Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 187. Asia Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 190. Asia Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 191. Asia Pharmaceuticals and Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 192. Asia Pharmaceuticals and Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 193. Asia Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 196. Asia Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 197. Asia Pharmaceuticals and Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 198. Asia Pharmaceuticals and Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 199. Asia Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Pharmaceuticals and Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 203. Asia Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 204. Asia Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 205. Asia Pharmaceuticals and Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 206. Asia Pharmaceuticals and Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 207. Japan Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 208. South Korea Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 209. India Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 210. Australia Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 211. China Taiwan Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 216. SAMEA Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 217. SAMEA Pharmaceuticals and Excipients Sales Price by Type (2021-2026) & (US$/Ton) Table 218. SAMEA Pharmaceuticals and Excipients Sales Price by Type (2027-2032) & (US$/Ton) Table 219. SAMEA Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 222. SAMEA Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 223. SAMEA Pharmaceuticals and Excipients Sales Price by Application (2021-2026) & (US$/Ton) Table 224. SAMEA Pharmaceuticals and Excipients Sales Price by Application (2027-2032) & (US$/Ton) Table 225. SAMEA Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Pharmaceuticals and Excipients Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 229. SAMEA Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 230. SAMEA Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 231. SAMEA Pharmaceuticals and Excipients Sales Price by Country (2021-2026) & (US$/Ton) Table 232. SAMEA Pharmaceuticals and Excipients Sales Price by Country (2027-2032) & (US$/Ton) Table 233. Brazil Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 234. Argentina Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 235. Chile Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 236. Colombia Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 237. Peru Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 239. Israel Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 240. UAE Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 241. Turkey Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 242. Iran Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 243. Egypt Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Pharmaceuticals and Excipients Distributors List Table 247. Pharmaceuticals and Excipients Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Pharmaceuticals and Excipients Image Figure 2. Global Pharmaceuticals and Excipients Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceuticals and Excipients Market Size Share 2021 VS 2025 VS 2032 Figure 4. Starch Image Figure 5. Mannitol Image Figure 6. Triglycerides Image Figure 7. Dextrose Image Figure 8. Sorbitol Image Figure 9. Sucrose Image Figure 10. Others Image Figure 11. Global Pharmaceuticals and Excipients Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceuticals and Excipients Market Size Share 2021 VS 2025 VS 2032 Figure 13. Parenteral Formulations Image Figure 14. Topical Formulations Image Figure 15. Oral Formulations Image Figure 16. Other Image Figure 17. Global Pharmaceuticals and Excipients Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Figure 19. Global Pharmaceuticals and Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceuticals and Excipients Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2021-2032) Figure 22. Global Pharmaceuticals and Excipients Sales (2021-2032) & (Tons) Figure 23. Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 24. Global Pharmaceuticals and Excipients Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Pharmaceuticals and Excipients Sales YoY (2021-2032) & (Tons) Figure 26. Europe Pharmaceuticals and Excipients Sales YoY (2021-2032) & (Tons) Figure 27. China Pharmaceuticals and Excipients Sales YoY (2021-2032) & (Tons) Figure 28. Asia (Excluding China) Pharmaceuticals and Excipients Sales YoY (2021-2032) & (Tons) Figure 29. South America, Middle East and Africa Pharmaceuticals and Excipients Sales YoY (2021-2032) & (Tons) Figure 30. Global Pharmaceuticals and Excipients Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Pharmaceuticals and Excipients Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Pharmaceuticals and Excipients Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pharmaceuticals and Excipients Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2032) Figure 36. Global Pharmaceuticals and Excipients Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Pharmaceuticals and Excipients Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2032) Figure 39. Global Pharmaceuticals and Excipients Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Pharmaceuticals and Excipients Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2032) Figure 42. Global Pharmaceuticals and Excipients Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 43. Global Pharmaceuticals and Excipients Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2032) Figure 45. North America Pharmaceuticals and Excipients Revenue Share by Type (2021-2032) Figure 46. North America Pharmaceuticals and Excipients Sales Share by Type (2021-2032) Figure 47. North America Pharmaceuticals and Excipients Revenue Share by Application (2021-2032) Figure 48. North America Pharmaceuticals and Excipients Sales Share by Application (2021-2032) Figure 49. North America Pharmaceuticals and Excipients Revenue Share by Country (2021-2032) Figure 50. North America Pharmaceuticals and Excipients Sales Share by Country (2021-2032) Figure 51. Europe Pharmaceuticals and Excipients Revenue Share by Type (2021-2032) Figure 52. Europe Pharmaceuticals and Excipients Sales Share by Type (2021-2032) Figure 53. Europe Pharmaceuticals and Excipients Revenue Share by Application (2021-2032) Figure 54. Europe Pharmaceuticals and Excipients Sales Share by Application (2021-2032) Figure 55. Europe Pharmaceuticals and Excipients Revenue Share by Country (2021-2032) Figure 56. Europe Pharmaceuticals and Excipients Sales Share by Country (2021-2032) Figure 57. China Pharmaceuticals and Excipients Revenue Share by Type (2021-2032) Figure 58. China Pharmaceuticals and Excipients Sales Share by Type (2021-2032) Figure 59. China Pharmaceuticals and Excipients Revenue Share by Application (2021-2032) Figure 60. China Pharmaceuticals and Excipients Sales Share by Application (2021-2032) Figure 61. Asia Pharmaceuticals and Excipients Revenue Share by Type (2021-2032) Figure 62. Asia Pharmaceuticals and Excipients Sales Share by Type (2021-2032) Figure 63. Asia Pharmaceuticals and Excipients Revenue Share by Application (2021-2032) Figure 64. Asia Pharmaceuticals and Excipients Sales Share by Application (2021-2032) Figure 65. Asia Pharmaceuticals and Excipients Revenue Share by Country (2021-2032) Figure 66. Asia Pharmaceuticals and Excipients Sales Share by Country (2021-2032) Figure 67. SAMEA Pharmaceuticals and Excipients Revenue Share by Type (2021-2032) Figure 68. SAMEA Pharmaceuticals and Excipients Sales Share by Type (2021-2032) Figure 69. SAMEA Pharmaceuticals and Excipients Revenue Share by Application (2021-2032) Figure 70. SAMEA Pharmaceuticals and Excipients Sales Share by Application (2021-2032) Figure 71. SAMEA Pharmaceuticals and Excipients Revenue Share by Country (2021-2032) Figure 72. SAMEA Pharmaceuticals and Excipients Sales Share by Country (2021-2032) Figure 73. Pharmaceuticals and Excipients Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Pharmaceuticals and Excipients Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Starch
  • Mannitol
  • Triglycerides
  • Dextrose
  • Sorbitol
  • Sucrose
  • Others
Applications
  • Parenteral Formulations
  • Topical Formulations
  • Oral Formulations
  • Other
Companies covered
  • Signet Chemical Corporation
  • Sigachi Industries
  • Shin-Etsu
  • Roquette
  • MEGGLE AG
  • Lubrizol
  • JRS Pharma
  • Evonik
  • ER-KANG
  • Dow
  • BASF
  • Ashland
  • ABITEC Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceuticals and Excipients Market by Type
  3. 1.2.1 Global Pharmaceuticals and Excipients Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Starch
  5. 1.2.3 Mannitol
  6. 1.2.4 Triglycerides
  7. 1.2.5 Dextrose
  8. 1.2.6 Sorbitol
  9. 1.2.7 Sucrose
  10. 1.2.8 Others
  11. 1.3 Pharmaceuticals and Excipients Market by Application
  12. 1.3.1 Global Pharmaceuticals and Excipients Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Parenteral Formulations
  14. 1.3.3 Topical Formulations
  15. 1.3.4 Oral Formulations
  16. 1.3.5 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Pharmaceuticals and Excipients Market Dynamics
  1. 2.1 Pharmaceuticals and Excipients Industry Trends
  2. 2.2 Pharmaceuticals and Excipients Industry Drivers
  3. 2.3 Pharmaceuticals and Excipients Industry Opportunities and Challenges
  4. 2.4 Pharmaceuticals and Excipients Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pharmaceuticals and Excipients Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pharmaceuticals and Excipients Revenue by Region
  3. 3.2.1 Global Pharmaceuticals and Excipients Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceuticals and Excipients Revenue by Region (2021-2026)
  5. 3.2.3 Global Pharmaceuticals and Excipients Revenue by Region (2027-2032)
  6. 3.2.4 Global Pharmaceuticals and Excipients Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pharmaceuticals and Excipients Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pharmaceuticals and Excipients Sales by Region
  9. 3.4.1 Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pharmaceuticals and Excipients Sales by Region (2021-2026)
  11. 3.4.3 Global Pharmaceuticals and Excipients Sales by Region (2027-2032)
  12. 3.4.4 Global Pharmaceuticals and Excipients Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pharmaceuticals and Excipients Revenue by Manufacturers
  2. 4.1.1 Global Pharmaceuticals and Excipients Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pharmaceuticals and Excipients Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pharmaceuticals and Excipients Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceuticals and Excipients Sales by Manufacturers
  6. 4.2.1 Global Pharmaceuticals and Excipients Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pharmaceuticals and Excipients Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pharmaceuticals and Excipients Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pharmaceuticals and Excipients Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pharmaceuticals and Excipients Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pharmaceuticals and Excipients Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pharmaceuticals and Excipients Manufacturers, Product Type & Application
  13. 4.7 Global Pharmaceuticals and Excipients Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pharmaceuticals and Excipients Market CR5 and HHI
  16. 4.8.2 2025 Pharmaceuticals and Excipients Tier 1, Tier 2, and Tier 3
5 Pharmaceuticals and Excipients Market by Type
  1. 5.1 Global Pharmaceuticals and Excipients Revenue by Type
  2. 5.1.1 Global Pharmaceuticals and Excipients Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pharmaceuticals and Excipients Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pharmaceuticals and Excipients Sales by Type
  6. 5.2.1 Global Pharmaceuticals and Excipients Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceuticals and Excipients Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pharmaceuticals and Excipients Price by Type
6 Pharmaceuticals and Excipients Market by Application
  1. 6.1 Global Pharmaceuticals and Excipients Revenue by Application
  2. 6.1.1 Global Pharmaceuticals and Excipients Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pharmaceuticals and Excipients Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pharmaceuticals and Excipients Sales by Application
  6. 6.2.1 Global Pharmaceuticals and Excipients Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pharmaceuticals and Excipients Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pharmaceuticals and Excipients Price by Application
7 Company Profiles
  1. 7.1 Signet Chemical Corporation
  2. 7.1.1 Signet Chemical Corporation Company Information
  3. 7.1.2 Signet Chemical Corporation Business Overview
  4. 7.1.3 Signet Chemical Corporation Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio
  6. 7.1.5 Signet Chemical Corporation Recent Developments
  7. 7.2 Sigachi Industries
  8. 7.2.1 Sigachi Industries Company Information
  9. 7.2.2 Sigachi Industries Business Overview
  10. 7.2.3 Sigachi Industries Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sigachi Industries Pharmaceuticals and Excipients Product Portfolio
  12. 7.2.5 Sigachi Industries Recent Developments
  13. 7.3 Shin-Etsu
  14. 7.3.1 Shin-Etsu Company Information
  15. 7.3.2 Shin-Etsu Business Overview
  16. 7.3.3 Shin-Etsu Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shin-Etsu Pharmaceuticals and Excipients Product Portfolio
  18. 7.3.5 Shin-Etsu Recent Developments
  19. 7.4 Roquette
  20. 7.4.1 Roquette Company Information
  21. 7.4.2 Roquette Business Overview
  22. 7.4.3 Roquette Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roquette Pharmaceuticals and Excipients Product Portfolio
  24. 7.4.5 Roquette Recent Developments
  25. 7.5 MEGGLE AG
  26. 7.5.1 MEGGLE AG Company Information
  27. 7.5.2 MEGGLE AG Business Overview
  28. 7.5.3 MEGGLE AG Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MEGGLE AG Pharmaceuticals and Excipients Product Portfolio
  30. 7.5.5 MEGGLE AG Recent Developments
  31. 7.6 Lubrizol
  32. 7.6.1 Lubrizol Company Information
  33. 7.6.2 Lubrizol Business Overview
  34. 7.6.3 Lubrizol Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lubrizol Pharmaceuticals and Excipients Product Portfolio
  36. 7.6.5 Lubrizol Recent Developments
  37. 7.7 JRS Pharma
  38. 7.7.1 JRS Pharma Company Information
  39. 7.7.2 JRS Pharma Business Overview
  40. 7.7.3 JRS Pharma Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 JRS Pharma Pharmaceuticals and Excipients Product Portfolio
  42. 7.7.5 JRS Pharma Recent Developments
  43. 7.8 Evonik
  44. 7.8.1 Evonik Company Information
  45. 7.8.2 Evonik Business Overview
  46. 7.8.3 Evonik Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Evonik Pharmaceuticals and Excipients Product Portfolio
  48. 7.8.5 Evonik Recent Developments
  49. 7.9 ER-KANG
  50. 7.9.1 ER-KANG Company Information
  51. 7.9.2 ER-KANG Business Overview
  52. 7.9.3 ER-KANG Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ER-KANG Pharmaceuticals and Excipients Product Portfolio
  54. 7.9.5 ER-KANG Recent Developments
  55. 7.10 Dow
  56. 7.10.1 Dow Company Information
  57. 7.10.2 Dow Business Overview
  58. 7.10.3 Dow Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dow Pharmaceuticals and Excipients Product Portfolio
  60. 7.10.5 Dow Recent Developments
  61. 7.11 BASF
  62. 7.11.1 BASF Company Information
  63. 7.11.2 BASF Business Overview
  64. 7.11.3 BASF Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 BASF Pharmaceuticals and Excipients Product Portfolio
  66. 7.11.5 BASF Recent Developments
  67. 7.12 Ashland
  68. 7.12.1 Ashland Company Information
  69. 7.12.2 Ashland Business Overview
  70. 7.12.3 Ashland Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ashland Pharmaceuticals and Excipients Product Portfolio
  72. 7.12.5 Ashland Recent Developments
  73. 7.13 ABITEC Corp
  74. 7.13.1 ABITEC Corp Company Information
  75. 7.13.2 ABITEC Corp Business Overview
  76. 7.13.3 ABITEC Corp Pharmaceuticals and Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ABITEC Corp Pharmaceuticals and Excipients Product Portfolio
  78. 7.13.5 ABITEC Corp Recent Developments
8 North America
  1. 8.1 North America Pharmaceuticals and Excipients Market Size by Type
  2. 8.1.1 North America Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  3. 8.1.2 North America Pharmaceuticals and Excipients Sales by Type (2021-2032)
  4. 8.1.3 North America Pharmaceuticals and Excipients Price by Type (2021-2032)
  5. 8.2 North America Pharmaceuticals and Excipients Market Size by Application
  6. 8.2.1 North America Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  7. 8.2.2 North America Pharmaceuticals and Excipients Sales by Application (2021-2032)
  8. 8.2.3 North America Pharmaceuticals and Excipients Price by Application (2021-2032)
  9. 8.3 North America Pharmaceuticals and Excipients Market Size by Country
  10. 8.3.1 North America Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pharmaceuticals and Excipients Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pharmaceuticals and Excipients Market Size by Type
  2. 9.1.1 Europe Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pharmaceuticals and Excipients Sales by Type (2021-2032)
  4. 9.1.3 Europe Pharmaceuticals and Excipients Price by Type (2021-2032)
  5. 9.2 Europe Pharmaceuticals and Excipients Market Size by Application
  6. 9.2.1 Europe Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pharmaceuticals and Excipients Sales by Application (2021-2032)
  8. 9.2.3 Europe Pharmaceuticals and Excipients Price by Application (2021-2032)
  9. 9.3 Europe Pharmaceuticals and Excipients Market Size by Country
  10. 9.3.1 Europe Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pharmaceuticals and Excipients Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Pharmaceuticals and Excipients Market Size by Type
  2. 10.1.1 China Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  3. 10.1.2 China Pharmaceuticals and Excipients Sales by Type (2021-2032)
  4. 10.1.3 China Pharmaceuticals and Excipients Price by Type (2021-2032)
  5. 10.2 China Pharmaceuticals and Excipients Market Size by Application
  6. 10.2.1 China Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  7. 10.2.2 China Pharmaceuticals and Excipients Sales by Application (2021-2032)
  8. 10.2.3 China Pharmaceuticals and Excipients Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceuticals and Excipients Market Size by Type
  2. 11.1.1 Asia Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pharmaceuticals and Excipients Sales by Type (2021-2032)
  4. 11.1.3 Asia Pharmaceuticals and Excipients Price by Type (2021-2032)
  5. 11.2 Asia Pharmaceuticals and Excipients Market Size by Application
  6. 11.2.1 Asia Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pharmaceuticals and Excipients Sales by Application (2021-2032)
  8. 11.2.3 Asia Pharmaceuticals and Excipients Price by Application (2021-2032)
  9. 11.3 Asia Pharmaceuticals and Excipients Market Size by Country
  10. 11.3.1 Asia Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pharmaceuticals and Excipients Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceuticals and Excipients Market Size by Type
  2. 12.1.1 SAMEA Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pharmaceuticals and Excipients Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pharmaceuticals and Excipients Price by Type (2021-2032)
  5. 12.2 SAMEA Pharmaceuticals and Excipients Market Size by Application
  6. 12.2.1 SAMEA Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pharmaceuticals and Excipients Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pharmaceuticals and Excipients Price by Application (2021-2032)
  9. 12.3 SAMEA Pharmaceuticals and Excipients Market Size by Country
  10. 12.3.1 SAMEA Pharmaceuticals and Excipients Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pharmaceuticals and Excipients Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pharmaceuticals and Excipients Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pharmaceuticals and Excipients Value Chain Analysis
  2. 13.1.1 Pharmaceuticals and Excipients Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pharmaceuticals and Excipients Production Mode & Process
  6. 13.2 Pharmaceuticals and Excipients Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pharmaceuticals and Excipients Distributors
  9. 13.2.3 Pharmaceuticals and Excipients Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research